The efficacy and toxicity of neoadjuvant carboplatin and paclitaxel administered on a weekly schedule for locally advanced cervical carcinoma were evaluated. Thirty patients staged as IB2-IVA according to the FIGO were treated with carboplatin (AUC 2; an area under the time-concentration of 2 mg*min/ml based on creatinine clearance) and paclitaxel (60 mg/m(2)) intravenously, every week for six cycles. A type III radical hysterectomy was then undertaken. Thirty patients were enrolled in this study. An objective response was recorded in 26 patients (87%, 95% CI 70-95%). Progressive disease was not observed. Grade 3 neutropenia was observed in only two patients (7%), and grade 1 or 2 neuropathy was seen in six patients (20%). The combination of carboplatin and paclitaxel given in weekly schedule for advanced cervical carcinoma was highly active, permitting a high rate of subsequent surgical resectability. It was well tolerated. This regimen may provide improved outcomes with minimal toxicity.
Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma. Publishing Authors By Initials
Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: International journal of gynecological cancer : of
VOLUME: 18
Page Numbers: 85-9
Journal Abbreviation: Int. J. Gynecol. Cancer
ISSN: 1048-891X
DAY: 22
MONTH: 06
YEAR: 2007
Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 9111626
Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma.
AFFILIATION: Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Int J Gynecol Cancer
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma Related Publications